These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 22034781)
1. Splenic irradiation in hematologic malignancies and other hematologic disorders--single institution experience. Soldić Z; Murgić J; Jazvić M; Radić J; Bolanca A; Stancić V; Kusić Z Acta Clin Croat; 2011 Mar; 50(1):29-35. PubMed ID: 22034781 [TBL] [Abstract][Full Text] [Related]
2. Low dose palliative radiotherapy for splenomegaly in hematologic disorders. Lavrenkov K; Krepel-Volsky S; Levi I; Ariad S Leuk Lymphoma; 2012 Mar; 53(3):430-4. PubMed ID: 21848363 [TBL] [Abstract][Full Text] [Related]
3. Short-time splenic irradiation for splenomegaly. Schratter-Sehn AU; Cerveny M; Simmel H; Schlögl E; Schratter A Onkologie; 2003 Feb; 26(1):21-4. PubMed ID: 12624513 [TBL] [Abstract][Full Text] [Related]
4. Low-dose palliative splenic irradiation in haematolymphoid malignancy. Shrimali RK; Correa PD; O'Rourke N J Med Imaging Radiat Oncol; 2008 Jun; 52(3):297-302. PubMed ID: 18477126 [TBL] [Abstract][Full Text] [Related]
5. Myelosuppression toxicity of palliative splenic irradiation in myelofibrosis and malignant lymphoma. Ishibashi N; Maebayashi T; Aizawa T; Sakaguchi M; Abe O; Saito T; Tanaka Y Hematology; 2015 May; 20(4):203-7. PubMed ID: 25131182 [TBL] [Abstract][Full Text] [Related]
6. Splenic irradiation for splenomegaly: A systematic review. Zaorsky NG; Williams GR; Barta SK; Esnaola NF; Kropf PL; Hayes SB; Meyer JE Cancer Treat Rev; 2017 Feb; 53():47-52. PubMed ID: 28063304 [TBL] [Abstract][Full Text] [Related]
7. Splenic irradiation as palliative treatment for symptomatic splenomegaly due to secondary myelofibrosis: a multi-institutional experience. Pistevou-Gombaki K; Zygogianni A; Kantzou I; Kyrgias G; Mystakidou K; Kouvaris J; Klonizakis I; Tsirigotis P; Pappa V; Siakantari M; Eleftheriadis N; Georgakopoulos J; Sarris G; Kelekis N; Kouloulias V J BUON; 2015; 20(4):1132-6. PubMed ID: 26416067 [TBL] [Abstract][Full Text] [Related]
8. [Splenic irradiation in the treatment of idiopathic myelofibrosis. Retrospective study of 14 cases]. Sciascia R; Mazza P; Tondi L Radiol Med; 1988; 76(1-2):87-90. PubMed ID: 3399713 [TBL] [Abstract][Full Text] [Related]
10. Palliative irradiation of the spleen. McFarland JT; Kuzma C; Millard FE; Johnstone PA Am J Clin Oncol; 2003 Apr; 26(2):178-83. PubMed ID: 12714892 [TBL] [Abstract][Full Text] [Related]
11. Splenic irradiation in the treatment of patients with chronic myelogenous leukemia or myelofibrosis with myeloid metaplasia. Results of daily and intermittent fractionation with and without concomitant hydroxyurea. Wagner H; McKeough PG; Desforges J; Madoc-Jones H Cancer; 1986 Sep; 58(6):1204-7. PubMed ID: 2427184 [TBL] [Abstract][Full Text] [Related]
12. Radiotherapy for splenomegaly. Mod H; Prasiko G; Jha AK; Chaurasia PP; Srivastava R JNMA J Nepal Med Assoc; 2005; 44(159):97-9. PubMed ID: 16554863 [TBL] [Abstract][Full Text] [Related]
13. A study of splenic irradiation in chronic lymphocytic leukemia. Guiney MJ; Liew KH; Quong GG; Cooper IA Int J Radiat Oncol Biol Phys; 1989 Jan; 16(1):225-9. PubMed ID: 2912945 [TBL] [Abstract][Full Text] [Related]
14. Splenic irradiation in the palliation of patients with lymphoproliferative and myeloproliferative disorders. Paulino AC; Reddy SP Am J Hosp Palliat Care; 1996; 13(6):32-5. PubMed ID: 8945101 [TBL] [Abstract][Full Text] [Related]
15. Value of low-dose 2 x 2 Gy palliative radiotherapy in advanced low-grade non-Hodgkin's lymphoma. Ng M; Wirth A; Ryan G; MacManus M; Davis S Australas Radiol; 2006 Jun; 50(3):222-7. PubMed ID: 16732818 [TBL] [Abstract][Full Text] [Related]
16. Adaptive splenic radiotherapy for symptomatic splenomegaly management in myeloproliferative disorders. Sager O; Beyzadeoglu M; Dincoglan F; Demiral S; Uysal B; Gamsiz H; Akin M; Gundem E; Dirican B Tumori; 2015; 101(1):84-90. PubMed ID: 25702680 [TBL] [Abstract][Full Text] [Related]
17. Repeated and preemptive palliative radiotherapy of symptomatic hepatomegaly in a patient with advanced myelofibrosis. Riesterer O; Gmür J; Lütolf U Onkologie; 2008 Jun; 31(6):325-7. PubMed ID: 18547974 [TBL] [Abstract][Full Text] [Related]
18. A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies. Sobecks RM; Daugherty CK; Hallahan DE; Laport GF; Wagner ND; Larson RA Bone Marrow Transplant; 2000 Apr; 25(8):807-13. PubMed ID: 10808200 [TBL] [Abstract][Full Text] [Related]
19. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy. Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536 [TBL] [Abstract][Full Text] [Related]
20. [Symptomatic irradiation therapy of the spleen in advanced osteomyelosclerosis]. Slanina J; Vondraczek A; Wannenmacher M Dtsch Med Wochenschr; 1986 Jul; 111(30):1144-50. PubMed ID: 2426078 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]